LNTH
Lantheus Holdings, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$101.10
+0.29%Forward multiples
Based on analyst estimates
- P/E forward
- 16.82x
- P/E 2026E
- 18.69x
- P/E 2027E
- 15.49x
- P/E 2028E
- 12.53x
- P/S forward
- 4.16x
Trailing multiples
Trailing twelve months
- P/E TTM
- 24.01x
- PEG TTM
- 0.56x
- Price / book
- 5.03x
- Price / sales
- 4.24x
- Price / cash flow
- 15.99x
Enterprise value
- Enterprise value
- $6.6B
- EV / sales
- 4.26x
- EV / EBITDA
- 14.07x
- EV / EBIT
- 21.94x
- Market cap
- $6.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026